Novo CEO pressed by Senate to cut rates of weight problems, diabetic issues medications CEO Lars Fruergaard Jørgensen told lawmakers the corporation would consider new talks with insurers with regard to the list prices of Wegovy and copyright should they pledge to help keep the medicines on their own formularies. https://zanehecyv.blogzet.com/not-known-factual-statements-about-healthcare-news-45485186